| Canis lupus familiaris |
Canis familiaris |
MED |
0.3 |
mg kg-1 |
10.1016/S0960-894X(00)80211-5 |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
nan |
None |
10.1021/jm300106z |
| Equus caballus |
Cholinesterase |
IC50 |
nan |
None |
10.1021/jm300106z |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Potency |
5623.4 |
nM |
None |
| Homo sapiens |
143B |
CC50 |
600000.0 |
nM |
10.1021/jm020299r |
| Homo sapiens |
143B |
CC50 |
700000.0 |
nM |
10.1021/jm020299r |
| Homo sapiens |
143B |
CC50 |
7000000.0 |
nM |
10.1021/jm030544m |
| Homo sapiens |
143B |
CC50 |
7400000.0 |
nM |
10.1021/jm030544m |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-63.83 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-2.04 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Parathyroid hormone receptor |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Skin |
log Kp |
-5.43 |
None |
10.1016/j.bmc.2007.07.050 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
86.27 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
114.2 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mus musculus |
EMT6 |
CC50 |
380000.0 |
nM |
10.1021/jm030544m |
| Mus musculus |
KBALB cell line |
CC50 |
97000.0 |
nM |
10.1021/jm030544m |
| Mus musculus |
KBALB cell line |
CC50 |
970000.0 |
nM |
10.1021/jm020299r |
| Mus musculus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Monoamine oxidase B |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Mus musculus |
AUC |
9256.69 |
ng.hr.mL-1 |
10.1016/j.bmc.2011.11.065 |
| Mus musculus |
Mus musculus |
IC50 |
nan |
None |
10.1016/j.ejmech.2016.07.039 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC90 |
nan |
None |
10.1016/j.ejmech.2016.07.039 |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
ED30 |
0.08 |
mg kg-1 |
10.1016/S0960-894X(01)81166-5 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Activity |
nan |
None |
10.1021/jm400951f |
| Rattus norvegicus |
Aorta |
EC50 |
25200.0 |
nM |
10.1021/jm300106z |
| Rattus norvegicus |
Rattus norvegicus |
EC50 |
4700.0 |
nM |
10.1021/jm0607247 |
| Rattus norvegicus |
Rattus norvegicus |
EC50 |
55000.0 |
nM |
10.1021/jm0607247 |
| Rattus norvegicus |
Rattus norvegicus |
EC50 |
100000.0 |
nM |
10.1021/jm0607247 |
| Rattus norvegicus |
Rattus norvegicus |
NO release |
1.9 |
% |
10.1021/jm020299r |
| Rattus norvegicus |
Rattus norvegicus |
NO release |
2.6 |
% |
10.1021/jm020299r |
| Rattus norvegicus |
Rattus norvegicus |
Reduction |
-75.0 |
% |
10.1016/S0960-894X(01)81166-5 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
33.0 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-9.77 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.11 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.07718 |
None |
10.1101/2020.04.03.023846 |
| Sus scrofa |
Artery |
EC50 |
420.0 |
nM |
10.1021/jm701491k |
| None |
ADMET |
CL |
3.6 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
31.0 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
CL |
59.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
118.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
CL |
180.0 |
mL.min-1.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
MRT |
1.0 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
1.69 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.05 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
1.7 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
1.9 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
3.0 |
L.kg-1 |
10.1002/jps.20373 |
| None |
ADMET |
Vdss |
4.9 |
mL/min/kg |
10.1002/jps.20373 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
KBALB-STK |
CC50 |
10000.0 |
nM |
10.1021/jm030544m |
| None |
KBALB-STK |
CC50 |
650000.0 |
nM |
10.1021/jm020299r |
| None |
Molecular identity unknown |
EC50 |
424.0 |
nM |
10.1016/j.bmcl.2007.08.046 |
| None |
Molecular identity unknown |
pD2 |
6.37 |
None |
10.1016/j.bmcl.2007.08.046 |
| None |
NON-PROTEIN TARGET |
Fu |
0.72 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
nan |
None |
10.1016/j.ejmech.2016.07.039 |
| None |
No relevant target |
Activity |
0.382 |
ug ml-1 |
10.1021/jm300106z |
| None |
No relevant target |
Activity |
4.0 |
uM |
10.1021/jm400951f |
| None |
No relevant target |
Activity |
7.17 |
mol/mol |
10.1016/j.ejmech.2016.07.039 |
| None |
No relevant target |
Activity |
11.6 |
% |
10.1021/jm300602n |
| None |
No relevant target |
Drug metabolism |
12.2 |
% |
10.1016/j.ejmech.2018.05.008 |
| None |
No relevant target |
LogP |
nan |
None |
10.1016/j.ejmech.2016.07.039 |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
Drug metabolism |
nan |
None |
10.1016/j.ejmech.2020.112768 |
| None |
Unchecked |
Hepatotoxicity (acute) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
NO release |
1.9 |
% |
10.1021/jm030544m |
| None |
Unchecked |
NO release |
2.6 |
% |
10.1021/jm030544m |
| None |
Unchecked |
NO release |
3.5 |
% |
10.1021/jm020299r |
| None |
Unchecked |
NO release |
3.5 |
% |
10.1021/jm030544m |
| None |
Unchecked |
NO release |
24.0 |
% |
10.1021/jm020299r |
| None |
Unchecked |
NO release |
24.0 |
% |
10.1021/jm030544m |
| None |
Unchecked |
Potency |
39810.7 |
nM |
None |
| None |
Unchecked |
Ratio IC50 |
nan |
None |
10.1021/jm300106z |
| None |
Unchecked |
Selectivity Index |
nan |
None |
10.1016/j.ejmech.2016.07.039 |